NASDAQ: CABA
Cabaletta Bio Inc Stock Ownership - Who owns Cabaletta Bio?

Insider buying vs selling

Have Cabaletta Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CABA insiders and whales buy or sell their stock.

CABA Shareholders

What type of owners hold Cabaletta Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc8.03%4,074,006$4.77MInstitution
Adage Capital Partners GP LLC7.16%3,634,473$4.25MInstitution
Blackrock Inc6.70%3,397,260$3.97MInstitution
Vanguard Group Inc5.65%2,867,722$3.36MInstitution
Bain Capital Life Sciences Investors LLC5.44%2,760,888$3.23MInstitution
Jennison Associates LLC4.95%2,512,053$2.94MInstitution
Fred Alger Management LLC4.56%2,316,224$2.71MInstitution
James E. Flynn3.21%1,628,506$1.91MInsider
Morgan Stanley2.84%1,439,165$1.68MInstitution
Steven Nichtberger2.66%1,349,483$1.58MInsider

1 of 3

CABA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CABA75.81%8.32%
RANI6.64%38.47%Net Selling
JSPR23.83%76.17%Net Buying
INZY55.76%44.24%Net SellingNet Selling
ACRV57.37%42.63%Net SellingNet Selling

Cabaletta Bio Stock Ownership FAQ

Who owns Cabaletta Bio?

Cabaletta Bio (NASDAQ: CABA) is owned by 75.81% institutional shareholders, 8.32% Cabaletta Bio insiders, and 15.87% retail investors. James E. Flynn is the largest individual Cabaletta Bio shareholder, owning 1.63M shares representing 3.21% of the company. James E. Flynn's Cabaletta Bio shares are currently valued at $2.08M.

If you're new to stock investing, here's how to buy Cabaletta Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.